Macrophage-targeted killing and vaccines

This publication has 13 references indexed in Scilit:

• Bispecific Molecules Directed to the Fc Receptor for IgA (FcαRI, CD89) and Tumor Antigens Efficiently Promote Cell-Mediated Cytotoxicity of Tumor Targets in Whole Blood
  The Journal of Immunology, 1998
• Clinical perspectives of bispecific antibodies in cancer
  Cancer Immunology, Immunotherapy, 1997
• Targeting tumor cell destruction with CD64-directed bispecific fusion proteins
  Cancer Immunology, Immunotherapy, 1997
• Cytolytic and cytostatic properties of an anti-human Fc gammaRI (CD64) x epidermal growth factor bispecific fusion protein.
  The Journal of Immunology, 1997
• F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.
  Journal of Clinical Investigation, 1996
• Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.
  Journal of Clinical Investigation, 1996
• Clinical Trials of Bispecific Antibody MDX-210 in Women with Advanced Breast or Ovarian Cancer that Overexpresses HER-2/neu
  Journal of Hematotherapy, 1995
• Production and Use of Anti-FcR Bispecific Antibodies
  ImmunoMethods, 1994
• Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens.
  The Journal of Immunology, 1992
• Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.
  The Journal of Immunology, 1989